Conference Coverage

High-intensity statins may cut risk of joint replacement

Publish date: May 16, 2019

 

REPORTING FROM OARSI 2019

SOURCE: Sarmanova A et al. Osteoarthritis cartilage. 2019 Apr;27[suppl 1]:S78-S79. Abstract 77.

Pages

Recommended Reading

Atorvastatin appears to lower cardiovascular risk in RA patients
MDedge Rheumatology
CD40 ligand–binding protein safely lowered RA disease activity
MDedge Rheumatology
FDA approves new etanercept biosimilar, Eticovo
MDedge Rheumatology
Lymphoma rate in RA patients is falling
MDedge Rheumatology
Methotrexate pneumonitis called ‘super rare’
MDedge Rheumatology
Interosseous tendon inflammation is common prior to RA
MDedge Rheumatology
Study compares tapering strategies in rheumatoid arthritis
MDedge Rheumatology
Arthritis joint pain, inactivity vary greatly across U.S.
MDedge Rheumatology
Higher infection risk in RA seen with high blood biologic levels
MDedge Rheumatology
VA system lags in getting DMARDs to veterans with inflammatory arthritis
MDedge Rheumatology